Antitumor Effects of Bacillus Calmette-Guerin Recombinant Protein PStS-3 on Xenografted Murine Bladder Carcinoma

被引：0
|
作者：
Lee, C. F. [1 ]
Yu, D. S. [2 ]
Chang, S. Y. [3 ]
Jiang, J. Y. [1 ]
机构：
[1] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan
[2] Natl Def Med Ctr, Dept Surg, Taipei, Taiwan
[3] Tri Serv Gen Hosp, Dept Surg, Taipei, Taiwan
来源：
FEBS JOURNAL | 2009年 / 276卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：323 / 323
页数：1
相关论文
共 50 条
  • [21] The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity
    Sinn, Haley W.
    Elzey, Bennett D.
    Jensen, Robert J.
    Zhao, Xiuqin
    Zhao, Weicheng
    Ratliff, Timothy L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (04) : 573 - 579
  • [22] THE EFFECTS OF RECOMBINANT BACILLUS CALMETTE-GUERIN RESISTANT TO ANTIMICROBIAL PEPTIDES ON ORTHOTOPIC BLADDER CANCER MOUSE MODEL
    Shim, Jae Hun
    Gook, Joonhee
    Choi, Se Young
    Chi, Byung Hoon
    Kim, Jin Wook
    Kim, Tae-Hyoung
    Myung, Soon Chul
    Chang, In Ho
    JOURNAL OF UROLOGY, 2021, 206 : E724 - E724
  • [23] Bacillus Calmette-Guerin: Is monthly maintenance an option for transitional cell carcinoma of the bladder?
    Flanigan, RC
    DeLaurentis, DA
    Waters, WB
    Kunz, K
    UROLOGIC ONCOLOGY, 2001, 6 (01): : 16 - 19
  • [24] Optimal Dose and Duration of bacillus Calmette-Guerin Therapy for Urothelial Carcinoma of the Bladder
    Homma, Yukio
    Nakagawa, Tohru
    JOURNAL OF UROLOGY, 2016, 195 (01): : 9 - 10
  • [25] BACILLUS CALMETTE-GUERIN: TREATMENT FOR SUPERFICIAL TRANSITIONAL CELL CARCINOMA (TCC) OF THE BLADDER
    Fornia, Samanta
    Ferretti, Stefania
    Campobasso, Davide
    Barbieri, Antonio
    Maestroni, Umberto
    Ziglioli, Francesco
    Cortellini, Pietro
    ANTICANCER RESEARCH, 2010, 30 (04) : 1523 - 1523
  • [26] Should intravesical Bacillus Calmette-Guerin be employed in transplant recipients with bladder carcinoma?
    Sun, H. -Y.
    Singh, N.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (04) : 358 - 362
  • [27] Predicting response to bacillus Calmette-Guerin (BCG) in patients with carcinoma in situ of the bladder
    Nunez-Nateras, Rafael
    Castle, Erik P.
    Protheroe, Cheryl A.
    Stanton, Melissa L.
    Ocal, Tolgay I.
    Ferrigni, Erin N.
    Ochkur, Sergei I.
    Jacobsen, Elizabeth A.
    Hou, Yue-Xian
    Andrews, Paul E.
    Colby, Thomas V.
    Lee, Nancy A.
    Lee, James J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 45.e23 - 45.e30
  • [28] EFFECTS OF LOCAL BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH BLADDER-CARCINOMA ON IMMUNOCOMPETENT CELLS OF THE BLADDER WALL
    BOHLE, A
    GERDES, J
    ULMER, AJ
    HOFSTETTER, AG
    FLAD, HD
    JOURNAL OF UROLOGY, 1990, 144 (01): : 53 - 58
  • [29] Immunological protection induced by bacillus Calmette-Guerin treatment in a murine bladder tumor model
    Iwasaki, A
    Kawai, K
    Hayashi, H
    Ikeda, N
    Toida, I
    Ohtani, M
    Akaza, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (04) : 219 - 224
  • [30] Reactive arthritis following treatment with intravesical Bacillus Calmette-Guerin for papillary carcinoma of bladder
    Singh, Yogesh Preet
    Roy, Debaditya
    Jois, Bhargavi
    Shetti, Mohit
    BMJ CASE REPORTS, 2022, 15 (04)
12345